Axess Shows Promise for Living HD Grafts

A synthetic, biocompatible blood vessel becomes colonized by a patient's own tissue. Now tested in 11 patients for more than 600 treatments, the new graft material is safe and works well—with no aneurysms or infections to date.

Read the full article » | Posted 05-12-2022

Related Articles

• Phraxis, Inc Seeking FDA 510(k) Clearance for InterGraft Posted 05-12-2022
• Invizius to Assess Way to Protect Peritoneal Membranes Posted 05-12-2022
• New Smart Valve Improves Catheter Function for Hemodialysis Posted 04-18-2022
• FistAssist Wins Breakthrough Designation Posted 04-18-2022